Vitamin D deficiency in schizophrenia implications for COVID-19 infection

Ir J Psychol Med. 2021 Dec;38(4):278-287. doi: 10.1017/ipm.2020.107. Epub 2020 Sep 11.

Abstract

Vitamin D deficiency is associated with an increased risk of acute respiratory infection. There is an excess of respiratory infections and deaths in schizophrenia, a condition where vitamin D deficiency is especially prevalent. This potentially offers a modifiable risk factor to reduce the risk for and the severity of respiratory infection in people with schizophrenia, although there is as yet no evidence regarding the risk of COVID-19. In this narrative review, we describe the prevalence of vitamin D deficiency in schizophrenia, report the research examining the relationship between vitamin D levels and COVID-19 and discuss the associations between vitamin D deficiency and respiratory infection, including its immunomodulatory mechanism of action.

Keywords: 25 (OH)D; antipsychotics; immune; pneumonia; psychosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Schizophrenia* / epidemiology
  • Vitamin D
  • Vitamin D Deficiency* / complications
  • Vitamin D Deficiency* / epidemiology

Substances

  • Vitamin D